🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Role of the Environment and Endocrine Disruptors in Child Cryptorchidism

Recruitingn/aAges 1 Month - 18 YearsMaleUniversity Hospital, Montpellier
NCT04342026 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Cryptorchidism is the most frequent congenital defect of the male newborn. It requires surgery in childhood, increases the risk of fertility disorders and cancer. As a major public health objective, it's the subject of numerous recommendations. Its frequency is increasing in some countries faster than a single genetic cause could not explain it. It may occurs in a geographic cluster. The cause of cryptorchidism involves genetic, hormonal and environmental factors. Animal studies suggest that endocrine disruptors interfere with fetal testicular migration. The aim of the study is to find out if some environmental exposition may be associated with cryptorchidism.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria: \- Parents of male children from the neonatal period to 18 years of age (during surgery) with cryptorchidism Exclusion criteria: * Parents of children without endocrine disease. (adrenal, hypothalamic-pituitary, phosphocalcic, thyroid, diabetes, etc.) * Parents of children without an associated genital or urinary defect (hypospadias, micropenis, renal and bladder abnormalities) * Testicular Ectopia (testis outside of normal migration path) * Anorchidism and evanescent testicles, united or bilateral * Abnormalities of the abdominal wall (laparoschisis, omphalocele, Prune Belly) * Cryptorchidism integrating in the context of a polymalformative syndrome, including neurological.
💊

What it tests

  • Measure of the exposure of parent of male with /without cryptorchidism to endocrine disruptors
📍

Where

1 site
University hospital of Montpellier
Montpellier, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy